AAAAAA

   
Results: 1-25 | 26-50 | 51-74
Results: 1-25/74
IMPROVED EFFICACY AND ENLARGED SPECTRUM OF ACTIVITY OF A NOVEL ANTHRACYCLINE DISACCHARIDE ANALOG OF DOXORUBICIN AGAINST HUMAN TUMOR XENOGRAFTS
Authors: PRATESI G DECESARE M CASERINI C PEREGO P DALBO L POLIZZI D SUPINO R BIGIONI M MANZINI S IAFRATE E SALVATORE C CASAZZA A ARCAMONE F ZUNINO F
Citation: G. Pratesi et al., IMPROVED EFFICACY AND ENLARGED SPECTRUM OF ACTIVITY OF A NOVEL ANTHRACYCLINE DISACCHARIDE ANALOG OF DOXORUBICIN AGAINST HUMAN TUMOR XENOGRAFTS, Clinical cancer research, 4(11), 1998, pp. 2833-2839
CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY
Authors: PRATESI G PEREGO P SUPINO R ZUNINO F
Citation: G. Pratesi et al., CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY, Clinical cancer research, 4(1), 1998, pp. 262-262
CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY
Authors: PRATESI G PEREGO P SUPINO R ZUNINO F
Citation: G. Pratesi et al., CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES - REPLY, Clinical cancer research, 4(1), 1998, pp. 262-262
OVARIAN-CANCER CISPLATIN-RESISTANT CELL-LINES - MULTIPLE CHANGES INCLUDING COLLATERAL SENSITIVITY TO TAXOL
Authors: PEREGO P ROMANELLI S CARENINI N MAGNANI I LEONE R BONETTI A PAOLICCHI A ZUNINO F
Citation: P. Perego et al., OVARIAN-CANCER CISPLATIN-RESISTANT CELL-LINES - MULTIPLE CHANGES INCLUDING COLLATERAL SENSITIVITY TO TAXOL, Annals of oncology, 9(4), 1998, pp. 423-430
IDARUBICIN DISACCHARIDE ANALOGS - MOLECULAR REQUIREMENTS FOR BIOACTIVITIES
Authors: CIPOLLONE A ANIMATI F ARCAMONE F BERETTONI M BIGIONI M CAPRANICO G ETTORRE A FRANCIOTTI M GUANO F PRATESI G SALVATORE C ZUNINO F
Citation: A. Cipollone et al., IDARUBICIN DISACCHARIDE ANALOGS - MOLECULAR REQUIREMENTS FOR BIOACTIVITIES, Annals of oncology, 9, 1998, pp. 106-106
BBR-3438 - A NEW 9-AZA-ANTHRAPYRAZOLE ENDOWED WITH HIGH ANTITUMOR-ACTIVITY IN HUMAN PROSTATIC-CARCINOMA XENOGRAFTS
Authors: BEGGIOLIN G PEZZONI G SPINELLI S MENTA E SUPINO R PRATESI G POLIZZI D PALUMBO M ZUNINO F
Citation: G. Beggiolin et al., BBR-3438 - A NEW 9-AZA-ANTHRAPYRAZOLE ENDOWED WITH HIGH ANTITUMOR-ACTIVITY IN HUMAN PROSTATIC-CARCINOMA XENOGRAFTS, Annals of oncology, 9, 1998, pp. 136-136
IN-VITRO AND IN-VIVO PHARMACODYNAMIC AND PHARMACOKINETIC PROFILE OF THE DISACCHARIDE ANTHRACYCLINE MEN10755 IN HUMAN OVARIAN-CANCER A2780
Authors: SALVATORE C BIGIONI M IAFRATE E MANZINI S GONZALESPAZ O PRATESI G GAMBETTA RA ZUNINO F
Citation: C. Salvatore et al., IN-VITRO AND IN-VIVO PHARMACODYNAMIC AND PHARMACOKINETIC PROFILE OF THE DISACCHARIDE ANTHRACYCLINE MEN10755 IN HUMAN OVARIAN-CANCER A2780, Annals of oncology, 9, 1998, pp. 193-193
SYNERGISTIC INTERACTION BETWEEN PACLITAXEL AND MEN-10755 IN HUMAN TUMOR XENOGRAFTS
Authors: PRATESI G POLIZZI D TORTORETO M ZUNINO F BIGIONI M MANZINI S ARCAMONE F
Citation: G. Pratesi et al., SYNERGISTIC INTERACTION BETWEEN PACLITAXEL AND MEN-10755 IN HUMAN TUMOR XENOGRAFTS, Annals of oncology, 9, 1998, pp. 350-350
IDN5109 - A NEW TAXANE WITH A BROAD-SPECTRUM OF ACTIVITY
Authors: POLIZZI D PRATESI G PEREGO P TORTORETO M BOMBARDELLI E RIVA A ZUNINO F
Citation: D. Polizzi et al., IDN5109 - A NEW TAXANE WITH A BROAD-SPECTRUM OF ACTIVITY, Annals of oncology, 9, 1998, pp. 356-356
CLAVILACTONES - PRECLINICAL EVALUATION OF A NOVEL CLASS OF TYROSINE KINASE INHIBITORS OF FUNGAL ORIGIN
Authors: CASSINELLI G LANZI C POLIZZI D GAMBETTA RA PENSA T MERLINI L NASINI G ZUNINO F
Citation: G. Cassinelli et al., CLAVILACTONES - PRECLINICAL EVALUATION OF A NOVEL CLASS OF TYROSINE KINASE INHIBITORS OF FUNGAL ORIGIN, Annals of oncology, 9, 1998, pp. 417-417
REGULATION OF SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING DRUGS BY REPAIR AND CHECKPOINT CONTROL GENES IN SCHIZOSACCHAROMYCES-POMBE
Authors: PEREGO P ZUNINO F CARENINI N GIULIANI F SPINELLI S HOWELL SB
Citation: P. Perego et al., REGULATION OF SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING DRUGS BY REPAIR AND CHECKPOINT CONTROL GENES IN SCHIZOSACCHAROMYCES-POMBE, Annals of oncology, 9, 1998, pp. 517-517
IN-VITRO AND IN-VIVO INTERACTION BETWEEN CISPLATIN AND TOPOTECAN IN OVARIAN-CARCINOMA SYSTEMS
Authors: ROMANELLI S PEREGO P PRATESI G CARENINI N TORTORETO M ZUNINO F
Citation: S. Romanelli et al., IN-VITRO AND IN-VIVO INTERACTION BETWEEN CISPLATIN AND TOPOTECAN IN OVARIAN-CARCINOMA SYSTEMS, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 385-390
FUNCTIONALIZATION OF A NON ACTIVATED C-H BOND - FLUORINATION OF VINDOLINE AT C-20 IN SUPERACIDS
Authors: BERRIER C JACQUESY JC JOUANNETAUD MP LAFITTE C VIDAL Y ZUNINO F FAHY J DUFLOS A
Citation: C. Berrier et al., FUNCTIONALIZATION OF A NON ACTIVATED C-H BOND - FLUORINATION OF VINDOLINE AT C-20 IN SUPERACIDS, Tetrahedron, 54(45), 1998, pp. 13761-13770
SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING COMPOUNDS OF SCHIZOSACCHAROMYCES-POMBE RAD MUTANTS
Authors: PEREGO P ZUNINO F CARENINI N GIULIANI F SPINELLI S HOWELL SB
Citation: P. Perego et al., SENSITIVITY TO CISPLATIN AND PLATINUM-CONTAINING COMPOUNDS OF SCHIZOSACCHAROMYCES-POMBE RAD MUTANTS, Molecular pharmacology, 54(1), 1998, pp. 213-219
MAPPING DRUG-INTERACTIONS AT THE COVALENT TOPOISOMERASE II-DNA COMPLEX BY BISANTRENE AMSACRINE CONGENERS/
Authors: CAPRANICO G GUANO F MORO S ZAGOTTO G SISSI C GATTO B ZUNINO F MENTA E PALUMBO M
Citation: G. Capranico et al., MAPPING DRUG-INTERACTIONS AT THE COVALENT TOPOISOMERASE II-DNA COMPLEX BY BISANTRENE AMSACRINE CONGENERS/, The Journal of biological chemistry, 273(21), 1998, pp. 12732-12739
HUMAN DNA TOPOISOMERASE II-ALPHA-DEPENDENT DNA CLEAVAGE AND YEAST CELL-KILLING BY ANTHRACYCLINE ANALOGS
Authors: BINASCHI M FARINOSI R AUSTIN CA FISHER LM ZUNINO F CAPRANICO G
Citation: M. Binaschi et al., HUMAN DNA TOPOISOMERASE II-ALPHA-DEPENDENT DNA CLEAVAGE AND YEAST CELL-KILLING BY ANTHRACYCLINE ANALOGS, Cancer research, 58(9), 1998, pp. 1886-1892
STIMULATION OF THE APOPTOTIC RESPONSE AS A BASIS FOR THE THERAPEUTIC SYNERGISM OF LONIDAMINE AND CISPLATIN IN COMBINATION IN HUMAN TUMOR XENOGRAFTS
Authors: DECESARE M PRATESI G GIUSTI A POLIZZI D ZUNINO F
Citation: M. Decesare et al., STIMULATION OF THE APOPTOTIC RESPONSE AS A BASIS FOR THE THERAPEUTIC SYNERGISM OF LONIDAMINE AND CISPLATIN IN COMBINATION IN HUMAN TUMOR XENOGRAFTS, British Journal of Cancer, 77(3), 1998, pp. 434-439
DECREASED DRUG ACCUMULATION AND INCREASED TOLERANCE TO DNA-DAMAGE IN TUMOR-CELLS WITH A LOW-LEVEL OF CISPLATIN RESISTANCE
Authors: LANZI C PEREGO P SUPINO R ROMANELLI S PENSA T CARENINI N VIANO I COLANGELO D LEONE R APOSTOLI P CASSINELLI G GAMBETTA RA ZUNINO F
Citation: C. Lanzi et al., DECREASED DRUG ACCUMULATION AND INCREASED TOLERANCE TO DNA-DAMAGE IN TUMOR-CELLS WITH A LOW-LEVEL OF CISPLATIN RESISTANCE, Biochemical pharmacology, 55(8), 1998, pp. 1247-1254
A PROTEIN-MEDIATED MECHANISM FOR THE DNA SEQUENCE-SPECIFIC ACTION OF TOPOISOMERASE-II POISONS
Authors: CAPRANICO G BINASCHI M BORGNETTO ME ZUNINO F PALUMBO M
Citation: G. Capranico et al., A PROTEIN-MEDIATED MECHANISM FOR THE DNA SEQUENCE-SPECIFIC ACTION OF TOPOISOMERASE-II POISONS, Trends in pharmacological sciences, 18(9), 1997, pp. 323-329
DOXORUBICIN DISACCHARIDE ANALOG - APOPTOSIS-RELATED IMPROVEMENT OF EFFICACY IN-VIVO
Authors: ARCAMONE F ANIMATI F BERETTONI M BIGIONI M CAPRANICO G CASAZZA AM CASERINI C CIPOLLONE A DECESARE M FRANCIOTTI M LOMBARDI P MADAMI A MANZINI S MONTEAGUDO E POLIZZI D PRATESI G RIGHETTI SC SALVATORE C SUPINO R ZUNINO F
Citation: F. Arcamone et al., DOXORUBICIN DISACCHARIDE ANALOG - APOPTOSIS-RELATED IMPROVEMENT OF EFFICACY IN-VIVO, Journal of the National Cancer Institute, 89(16), 1997, pp. 1217-1223
ROLE OF APOPTOSIS AND APOPTOSIS-RELATED PROTEINS IN THE CISPLATIN-RESISTANT PHENOTYPE OF HUMAN TUMOR-CELL LINES
Authors: PEREGO P RIGHETTI SC SUPINO R DELIA D CASERINI C CARENINI N BEDOGNE B BROOME E KRAJEWSKI S REED JC ZUNINO F
Citation: P. Perego et al., ROLE OF APOPTOSIS AND APOPTOSIS-RELATED PROTEINS IN THE CISPLATIN-RESISTANT PHENOTYPE OF HUMAN TUMOR-CELL LINES, Apoptosis, 2(6), 1997, pp. 540-548
APOPTOSIS AS A DETERMINANT OF TUMOR SENSITIVITY TO TOPOTECAN IN HUMANOVARIAN-TUMORS - PRECLINICAL IN-VITRO IN-VIVO STUDIES
Authors: CASERINI C PRATESI G TORTORETO M BEDOGNE B CARENINI N SUPINO R PEREGO P RIGHETTI SC ZUNINO F
Citation: C. Caserini et al., APOPTOSIS AS A DETERMINANT OF TUMOR SENSITIVITY TO TOPOTECAN IN HUMANOVARIAN-TUMORS - PRECLINICAL IN-VITRO IN-VIVO STUDIES, Clinical cancer research, 3(6), 1997, pp. 955-961
DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L DELVECCHIO M ARTALE S ZUNINO F BIGNAMI P MAGNANI E BUZZONI R
Citation: E. Bajetta et al., DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS, European journal of cancer, 33(4), 1997, pp. 687-690
CYTOTOXIC AND ANTITUMOR-ACTIVITY OF MEN-10710, A NOVEL ALKYLATING DERIVATIVE OF DISTAMYCIN
Authors: BIGIONI M SALVATORE C PALMA C MANZINI S ANIMATI F LOMBARDI P PRATESI G SUPINO R ZUNINO F
Citation: M. Bigioni et al., CYTOTOXIC AND ANTITUMOR-ACTIVITY OF MEN-10710, A NOVEL ALKYLATING DERIVATIVE OF DISTAMYCIN, Anti-cancer drugs, 8(9), 1997, pp. 845-852
CAMPTOTHECINS - MECHANISM OF ACTION AND PRECLINICAL STUDIES
Authors: ZUNINO F POLIZZI D PRATESI G
Citation: F. Zunino et al., CAMPTOTHECINS - MECHANISM OF ACTION AND PRECLINICAL STUDIES, Tumori, 83(6), 1997, pp. 3-10
Risultati: 1-25 | 26-50 | 51-74